A Comparative View on Human Somatic Cell Sources for iPSC Generation
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
The breakthrough of reprogramming human somatic cells was achieved in 2006 by the work of Yamanaka and Takahashi. From this point, fibroblasts are the most commonly used primary somatic cell type for the generation of induced pluripotent stem cells (iPSCs). Various characteristics of fibroblasts supported their utilization for the groundbreaking experiments of iPSC generation. One major advantage is the high availability of fibroblasts which can be easily isolated from skin biopsies. Furthermore, their cultivation, propagation, and cryoconservation properties are uncomplicated with respect to nutritional requirements and viability in culture. However, the required skin biopsy remains an invasive approach, representing a major drawback for using fibroblasts as the starting material. More and more studies appeared over the last years, describing the reprogramming of other human somatic cell types. Cells isolated from blood samples or urine, as well as more unexpected cell types, like pancreatic islet beta cells, synovial cells, or mesenchymal stromal cells from wisdom teeth, show promising characteristics for a reprogramming strategy. Here, we want to highlight the advantages of keratinocytes from human plucked hair as a widely usable, noninvasive harvesting method for primary material in comparison with other commonly used cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reprogramming efficiency is also higher for these two cell types and requires relatively less time for reprogramming [11,12].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299 · cited 1×
“On the other hand, its oncogenic potential suggests its omission for clinical applications [19].”
BackgroundHematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Epigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313 · cited 1×
“the epigenetic memory after prolonged iPS cell culture which leads to the conclusion that the primary cell source may not be absolutely essential for redifferentiation [34, 35].”
BackgroundGeneration of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009 · cited 2×
“Moreover, also these systems exhibit a low reprogramming efficiency compared to other systems [10, 21].”
BackgroundMethodGeneration of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606 · cited 1×
“To avoid the use of integrating viruses, other reprogramming approaches, for example, the use of Sendai viruses [9], plasmids [10], modified RNA [11], or small molecules [12, 13], have been described.”
MethodHotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G., Antosiewicz-Bourget, J., O’Malley, R., Castanon, R., Klugman, S., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,549 · cited 1×
“The general reprogramming process changes the transcriptome and chromatin state of the somatic cell to that of a pluripotent cell [24].”
Background
Cited by
Items 101–200 of 262
Current standards and pitfalls associated with the transfection of primary fibroblast cells
Kucharski, M., Mrowiec, P., & Oclon, E. A. (2021) · Biotechnology Progress · doi:10.1002/btpr.3152 · Cited by 27
“blasts is to use this primary somatic cell type for the generation of induced pluripotent stem cells (iPSCs).(13) Furthermore, dermal fibroblasts are ideal candidates for large-scale cell-based gene therapy.”
BackgroundBiomedical Application of Dental Tissue‐Derived Induced Pluripotent Stem Cells
Lee, J., & Seo, S.-J. (2016) · Stem Cells International · doi:10.1155/2016/9762465 · Cited by 19
“All iPSCs have genomic instability and a big rate of tumorigenicity in vivo [48, 49].”
Foggia, V. D., Makwana, P., Ali, R. R., & Sowden, J. C. (2016) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0143 · Cited by 17
“iPSC have been so far reprogrammed from several different somatic cells types, including fibroblasts,(15,16) blood mononuclear cells,(17) peripheral blood cells,(18) human astrocytes,(19) renal epithelial cells present in urine,(20) and different types of cells associated with the hair (keratinocytes,(21) follicle der…”
BackgroundShan, D., Song, Y., Zhang, Y., Ho, C. W., Xia, W., Li, Z., Ge, F., Ou, Q., Dai, Z., & Dai, Z. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1297374 · Cited by 16
Musgrove, L., Russell, F. D., & Ventura, T. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2342480 · Cited by 17
“However, since their initial creation, iPSCs have proven to be relatively simple to generate from many different cell types and species, so it may be feasible (Raab et al. 2014; Rosselló et al. 2013).”
From Hair to iPSCs—A Guide on How to Reprogram Keratinocytes and Why
Klingenstein, S., Klingenstein, M., Kleger, A., & Liebau, S. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.121 · Cited by 16
Self-citationTargeting cell plasticity for regeneration: From in vitro to in vivo reprogramming
Romanazzo, S., Lin, K., Srivastava, P., & Kilian, K. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.007 · Cited by 17
“Follicular keratinocytes can be isolated from different types of hair, and have proved very successful in reprogramming in short times with high efficiency [42].”
BackgroundUnterholzner, J., Millischer, V., Wotawa, C., Sawa, A., & Lanzenberger, R. R. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab037 · Cited by 17
“Fibroblasts currently still represent the main source for the generation of iPSCs (Raab et al., 2014).”
BackgroundStem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future Directions
Le, N. T., Dunleavy, M. W., Zhou, W., Bhatia, S. S., Kumar, R. D., Woo, S. T., Ramirez-Pulido, G., Ramakrishnan, K. S., & El-Hashash, A. H. K. (2025) · Biomedicines · doi:10.3390/biomedicines13051209 · Cited by 20
“They can be isolated from virtually any differentiated adult somatic tissue, though the most common sources are skin-derived fibroblasts or peripheral blood [33].”
Peng, G.-Y., Lin, Y., Li, J., Wang, Y., Huang, H., & Shen, Z. (2019) · Stem Cells International · doi:10.1155/2019/9613258 · Cited by 13
“Other cell types from diverse developmental origins, such as hepatocytes (endoderm origin), circulating T cells (mesoderm), and keratinocytes (ectoderm), have also been successfully reprogrammed into iPSCs even with different efficiency [4].”
Kao, C., Mills, J. A., Burke, C. J., Morse, B. A., & Marques, B. F. (2023) · Biology · doi:10.3390/biology12050677 · Cited by 13
An, L., Yuan, S., Cheng, L., Huo, F., Yang, C., & Tian, W. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04818-0 · Cited by 14
“…[94–96], peripheral blood mononuclear cells (PBMNCs) [98], keratinocytes from plucked hair [99], urine-derived cells [100], and mesenchymal stromal cells from wisdom teeth [101]. iPSC-derived cell sheets are under clinical investigation for ocular, cardiovascular, and metabolic disorders.”
Comparing stem cells, transdifferentiation and brain organoids as tools for psychiatric research
Bellon, A. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02780-8 · Cited by 17
“Shortly after the discovery of IPSCs, retroviruses were replaced by lentiviruses [64].”
BackgroundMethodYavarpour‐Bali, H., Nakhaei‐Nejad, M., Yazdi, A., & Ghasemi‐Kasman, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29195 · Cited by 12
“In addition, GRP cells can be differentiated into OLs, type 1 astrocytes, and type 2 astrocytes, whereas, OPCs (O2A/OPCs) only produce type 2 astrocytes and OLs (Rao et al., 1998).”
BackgroundVon Willebrand Disease: From In Vivo to In Vitro Disease Models
de Boer, S., & Eikenboom, J. C. J. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000297 · Cited by 13
“The attractiveness of this system is that the same patient-speci fi c iPSCs batch can be used to differentiate into a variety of cell types of interest.”
Parafati, M., Bae, S. H., Kirby, R. J., Fitzek, M., Iyer, P., Engkvist, O., Smith, D. M., & Malany, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249557 · Cited by 14
Gao, X., Yourick, J. J., & Sprando, R. L. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_372 · Cited by 12
Sundaravadivelu, P. K., Raina, K., Thool, M., Ray, A., Joshi, J. M., Kaveeshwar, V., Selvaraju, S., Lenka, N., & Thummer, R. P. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_660 · Cited by 13
Benchoua, A., Lasbareilles, M., & Tournois, J. (2021) · Cells · doi:10.3390/cells10123290 · Cited by 15
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
Guo, X., Wang, X., Wang, J., Ma, M., & Ren, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083774 · Cited by 17
“Mes-enchymal stem cells (MSCs), derived from tissues such as bone marrow, adipose tissue, and teeth, are another accessible and widely utilized source, particularly in studies involving regeneration and differentiation [38,49].”
Scarnati, M. S., Halikere, A., & Pang, Z. P. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.03.008 · Cited by 11
“…characteristics that make them ideal for reprogramming, including the ease of cultivation in culture and low methylation levels of the promoter regions for genes expressed in the early embryo, such as OCT4 and NANOG, thus granting the appropriate TFs access to the promoter (Raab et al., 2014).”
BackgroundHuman iPSC Reprogramming Success: The Impact of Approaches and Source Materials
Pozner, T., Grandizio, C., Mitchell, M. W., Turan, N., & Scheinfeldt, L. (2025) · Stem Cells International · doi:10.1155/sci/2223645 · Cited by 13
“Among the alternative cell sources, whole blood has become increasingly favoured for its minimally invasive collection procedure [21].”
Liu, W., Zhang, P., Tan, J., & Lin, Y. (2020) · Cellular Reprogramming · doi:10.1089/cell.2019.0088 · Cited by 10
“Urine specimens is a novel and noninvasive approach to isolate patient-specific stem cells by easy and low-cost procedures and negligibly invasive way and retain up to 0.1%–4% of re-programming ability that is much more than blood cells and fibroblasts (Falzarano and Ferlini, 2019; Raab et al., 2014).”
InfluentialCobb, H., Aparicio‐Domingo, S., & Canto-Soler, M. V. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.10.9 · Cited by 11
Cellular therapies and stem cell applications in trauma
Wang, Y., Pati, S., & Schreiber, M. A. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.02.003 · Cited by 12
Cellular Models: HD Patient-Derived Pluripotent Stem Cells
Smith-Geater, C., Hernandez, S. J., Thompson, L. M., & Mattis, V. B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_4 · Cited by 11
Generation of Induced Pluripotent Stem Cells from Human Epidermal Keratinocytes
Yang, Y., Zhang, R., Cheng, S., Xu, B., Tian, T., Shi, H., Xiao, L., & Chen, R. (2018) · Cellular Reprogramming · doi:10.1089/cell.2018.0035 · Cited by 10
“Keratinocytes have emerged as a promising cell source for reprogramming, not only because of their easy availability but also due to their higher reprogramming efficiency (Raab et al., 2014).”
Roh, E. Y., Oh, S., Yoon, J. H., Kim, B. J., Song, E. Y., & Shin, S. (2020) · Cell Transplantation · doi:10.1177/0963689720926151 · Cited by 12
Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development
Feng, L., Wang, Y., Fu, Y., Li, T., & He, G. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10672-5 · Cited by 9
“However, a longer timeframe, lower efficiency of induction, and difficulty in obtaining cells of origin hinder the application of fibroblasts [122].”
Baas, F. S., Rishi, G., Swinkels, D. W., & Subramaniam, V. N. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab130 · Cited by 11
Polyphenols in Inner Ear Neurobiology, Health and Disease: From Bench to Clinics
Osakabe, N., Modafferi, S., Ontario, M. L., Rampulla, F., Zimbone, V., Migliore, M. R., Fritsch, T., Abdelhameed, A. S., Maiolino, L., Lupo, G., et al. (2023) · Medicina · doi:10.3390/medicina59112045 · Cited by 13
“…and the development of three-dimensional organoid models boosted the opportunities for studying brain function and disorders in in vitro models. hiPSCs are generated by reprogramming adult human cells, obtained from tissues such as skin, blood, or urine, into a pluripotent state [204,205].”
BackgroundSong, H. W., Solomon, J. N., Masri, F., Mack, A. A., Durand, N., Cameau, E., Dianat, N., Hunter, A. L., Oh, S., Schoen, B., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.05.024 · Cited by 14
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery
Sen, C. K., Friday, A. J., & Roy, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100077 · Cited by 11
Strittmatter, G. E., Garstkiewicz, M., Sand, J., Grossi, S., & Beer, H. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3804-9_9 · Cited by 9
Reprogramming to pluripotency does not require transition through a primitive streak-like state
Raab, S., Klingenstein, M., Möller, A., Illing, A., Tošić, J., Breunig, M., Kuales, G., Linta, L., Seufferlein, T. T. W., Arnold, S. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15187-x · Cited by 9
Self-citationCardiovascular Imaging Databases: Building Machine Learning Algorithms for Regenerative Medicine
Mehta, C., Shah, R., Yanamala, N. V. K., & Sengupta, P. P. (2022) · Current Stem Cell Reports · doi:10.1007/s40778-022-00216-x · Cited by 9
“In addition, there is high variability in hiPSC differentiation outcomes [38–40].”
BackgroundMartín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03300-z · Cited by 8
Future prospects in the tissue engineering of heart valves: a focus on the role of stem cells
Albert, B. J., & Butcher, J. T. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2214313 · Cited by 8
“The cell populations discussed all have features of stemness that allow them to be used effectively to differentiate toward heart valve cell types, however they all start at slightly different phenotypes [114,115].”
BackgroundInhibition of TGF-β signaling enhances osteogenic potential of iPSC-derived MSCs
Umrath, F., Frick, S., Wendt, V., Naros, A., Zimmerer, R. M., & Alexander, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-89370-w · Cited by 9
Thiab, S., Azeez, J. M., Anala, A. D., Nanda, M., Khan, S., Butler, A. E., & Nandakumar, M. (2025) · Cells · doi:10.3390/cells14151188 · Cited by 12
“While a variety of adult somatic cell types exist as precursors for iPSC generation, fibroblasts and peripheral blood mononuclear cells (PBMCs) have proven to be the most convenient sources of somatic cells, due to easy availability and viability in culture [9].”
Dandapani, S., & Hwang, Y. (2026) · Mechanobiology · doi:10.1177/29780241261418480 · Cited by 9
Induced Pluripotent Stem Cells in Pediatric Research and Clinical Translation
Uçkan, D., & Haider, K. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-77052-5_13 · Cited by 11
Cancer-associated fibroblasts in acute leukemia
Gu, L., Liao, P. H., & Liu, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1022979 · Cited by 9
In vitro human cell culture models in a bench‐to‐bedside approach to epilepsy
Danačíková, Š., Straka, B., Daněk, J., Kořínek, V., & Otáhal, J. (2024) · Epilepsia Open · doi:10.1002/epi4.12941 · Cited by 8
“[94]).”
Cassotta, M., Díaz, Y. A., Qi, Z., Yang, B., Grosso, G., Quiles, J. L., Battino, M. A., Godos, J., & Giampieri, F. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.104980 · Cited by 14
Chakrabarty, K., Shetty, R., Argulwar, S., Das, D., & Ghosh, A. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.08.003 · Cited by 8
“Thus far, iPSCs have been generated from almost all types of somatic cells [50].”
BackgroundIn vitro induced pluripotency from urine-derived cells in porcine
Recchia, K., Machado, L. S., Botigelli, R. C., Pieri, N. C. G., Barbosa, G., de Castro, R. V. G., Marques, M. G., Pessôa, L. V. D. F., Neto, P. F., Meirelles, F. V., et al. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i3.231 · Cited by 10
Moerkens, R., Mooiweer, J., Smits, E., Berg, M., Ramírez-Sánchez, A. D., Modderman, R., Puschhof, J., Pleguezuelos‐Manzano, C., Barrett, R. J., Wijmenga, C., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102715 · Cited by 7
Fatehi, A. K., Sadat, M., Fayyad, M., Tang, J., Han, D., Rogers, I. M., & Taylor, D. W. (2024) · Cells · doi:10.3390/cells13121010 · Cited by 9
“This mirrors the high transfection efficiency seen for keratinocytes when compared to other cell sources, such as fibroblast and umbilical cord tissue [43,44].”
BackgroundBeyond skin deep: Revealing the essence of iPS cell-generated skin organoids in regeneration
Zhang, Y.-X., Zhou, Y., Xiong, Y., & Li, Y. (2024) · Burns · doi:10.1016/j.burns.2024.06.011 · Cited by 9
Lei, Q., Zhang, R., Yuan, F., & Xiang, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312947 · Cited by 11
“In fact, a large number of somatic cells have been reprogrammed into iPSCs, including fibroblasts, keratinocytes, melanocytes, adipose cells, peripheral blood cells, periosteum membrane cells, hepatocytes, and amniocytes [18].”
Wüstner, L.-S., Klingenstein, M., Frey, K. G., Nikbin, M. R., Milazzo, A., Kleger, A., Liebau, S., & Klingenstein, S. (2022) · Cells · doi:10.3390/cells11121955 · Cited by 7
“Procedural invasiveness in obtaining primary cells, transportation, cultivation in vitro and reprogramming efficiency are challenges to take into account when choosing the appropriate somatic cell source [8].”
BackgroundSelf-citationBelle, K. C., Shabazz, F. S., Nuytemans, K., Davis, D. A., Ali, A., Young, J. L., Scott, W. K., Mash, D. C., Vance, J. M., & Dykxhoorn, D. M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.065 · Cited by 7
cGMP Generation of Human Induced Pluripotent Stem Cells with Messenger RNA
Ni, Y., Zhao, Y., Warren, L. A., Higginbotham, J. M., & Wang, J. (2016) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.18 · Cited by 7
Prospective applications of induced pluripotent stem cells in military medicine
Saha, B., Kumar, H. K., Borgohain, M. P., & Thummer, R. P. (2018) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2018.03.005 · Cited by 9
Tsai, R., Shrestha, R., & Wen, Y. (2019) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_147_19 · Cited by 9
“iPSC-derived photoreceptor cells have been established from various cell sources such as blood, fibroblast, and keratinocytes [56,68,72,91].”
BackgroundHuman iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Koh, H., Xing, Z., Kim, J., Ha, H., & Lee, J. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102674 · Cited by 6
Influence of Cell Type in In Vitro Induced Reprogramming in Cattle
Recchia, K., Pessôa, L. V. D. F., Pieri, N. C. G., Pires, P. R. L., & Bressan, F. F. (2022) · Life · doi:10.3390/life12081139 · Cited by 6
“The biPSCs previously reported were generated in a divergent condition of culture in vitro, as reported for the supplementation with LIF (leukemia inhibitory factor) and BMP4 (bone morphogenetic protein 4) [25,29], or LIF and/or bFGF (basic fibroblast grow factor) [32].”
BackgroundBehl, T., Kaur, I., Sehgal, A., Singh, S., Sharma, N., Chigurupati, S., Felemban, S. G., Alsubaiyel, A. M., Iqbal, M. S., Bhatia, S., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10390-4 · Cited by 6
Bachour-El Azzi, P., Chesné, C., & Uehara, S. (2022) · Advances in Pharmacology · doi:10.1016/bs.apha.2022.05.009 · Cited by 6
Kuzma-Hunt, A. G., Shah, V., DiMarco, S., Russell, K. A., Betts, D. H., & Koch, T. G. (2023) · Stem Cells and Development · doi:10.1089/scd.2022.0300 · Cited by 7
“Fibroblasts appear to be the most common cell type used to generate hiPSCs because of their availability from skin biopsy and reliable outcomes following cultivation, propagation, and cryopreservation [41].”
BackgroundDevelopment of small‐molecule‐induced fibroblast expansion technologies
Sidal, H., Erkan, P. C., Uslu, M., & Kocabaş, F. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3112 · Cited by 6
Naffaa, M. M. (2025) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-25-00013 · Cited by 8
Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling
Rashidan, K., Ayadilord, M., Hazrati, A., Nazerian, A., Shafiee, A., & Hashemi, S. M. (2025) · MedComm · doi:10.1002/mco2.70531 · Cited by 8
“In comparison to iPSC-derived immune cells this approach is more economical [236].”
Weber, M., Linti, C., Lörch, C., Weber, M., Andt, M., Schlensak, C., Wendel, H. P., Doser, M., & Avci‐Adali, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-49117-x · Cited by 7
“A widely used strategy to obtain hiPSCs that can be further differentiated into the desired cell type, such as hepatocytes, is to reprogram skin fibroblasts using viral vectors 29,30 .”
The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment
Das, M. K., Lunavat, T. R., Miletić, H., & Hossain, J. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_619 · Cited by 5
Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD
Ohki, C. M. Y., McNeill, R. V., Nieberler, M., Radtke, F., Kittel‐Schneider, S., & Grünblatt, E. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_346 · Cited by 5
Ali, H. R. W., Suliman, S., Osman, T., Carrasco, M., Bruland, O., Costea, D. E., Ræder, H., & Mustafa, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03403-7 · Cited by 6
“Studies have revealed, for example, that keratinocytes are more easily reprogrammed than fibroblasts and that dental pulp stem cells yield more iPS colonies than bone marrow MSC [30, 33].”
BackgroundHameed, S. S., & Sharma, T. P. (2025) · Current Protocols · doi:10.1002/cpz1.70091 · Cited by 6
Yan, X., Xu, N., Meng, C., Wang, B., Yuan, J., Wang, C., & Li, Y. (2016) · PubMed · Cited by 6
Shin, S., Song, E. Y., Kwon, Y., Oh, S., Park, H., Kim, N., & Roh, E. Y. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.05.008 · Cited by 6
Requirements for designing organ-on-a-chip platforms to model the pathogenesis of liver disease
Ishida, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817202-5.00005-x · Cited by 6
Shrestha, R. (2020) · Progress in Stem Cell · doi:10.15419/psc.v7i1.409 · Cited by 5
Kajihara, R., Numakawa, T., & Era, T. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3914 · Cited by 6
“…researchers can establish disease-specific iPSCs from patients’ somatic cells, including skin fibroblasts, keratinocytes, cord blood-derived endothelial cells, peripheral blood mononuclear cells, and surprisingly tumor cells (Raab et al., 2014; Marin Navarro et al., 2018; Saha et al., 2018).”
BackgroundIsolation of induced pluripotent cells from stromal liver cells of patients with alcoholic cirrhosis
Kholodenko, I. V., Kholodenko, R. V., Manukyan, G. V., Lupatov, A. Y., & Yarygin, K. N. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3845-4 · Cited by 5
“It was shown that iPSC can be derived from the majority of differentiated and progenitor (partially differentiated) cells [11].”
BackgroundDesign and implementation of an integrated scanning protocol for multimodal functional OCT
Feng, Z., Zhang, T., Wang, M., Huang, Z., & Li, C. (2025) · Biomedical Optics Express · doi:10.1364/boe.573399 · Cited by 4
“Skin biopsy is considered the gold standard for obtaining comprehensive diagnostic information but comes with drawbacks, which include being invasive [15], delayed results due to processing time [16] and potential risks such as infection [17].”
Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease Modeling
Dorota, A., Maryniak, N., Mariankowska, A., Milczarek, C., Dorota, M., Żywiec, W., Kozlowski, K., Koval, I., Czyżewski, B. M., & Czyzewska, J. (2025) · Cureus · doi:10.7759/cureus.93999 · Cited by 11
Investigating Inherited Heart Diseases Using Human Induced Pluripotent Stem Cell-Based Models
Wang, B. (2024) · Life · doi:10.3390/life14111370 · Cited by 4
Hair growth stimulation by a Natural Remedy: Animal Studies
Vishnyakova, K. S., Vetkova, L. G., Jasko, M. V., Aliper, A. M., Buzdin, A. A., Popov, K. V., Kudryavtseva, A. V., & Yegorov, Y. E. (2018) · Madridge Journal of Dermatology & Research · doi:10.18689/mjdr-1000109 · Cited by 4
“The outer root sheet is visible as a white layer covering the root [29].”
BackgroundA roadmap for neurodevelopmental disease modeling for non-stem cell biologists
Ernst, C. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0344 · Cited by 4
Modelling Cardiovascular Diseases Using Human Microphysiological Systems
Ribeiro, Q., Lopes, E., Ferreira, I. S., Simões, C. G., Vital, C. M., Inácio, J. M., Belo, J. A., Rybak‐Wolf, A., Marques, A. R. A., & Vieira, O. V. (2026) · BioChip Journal · doi:10.1007/s13206-025-00247-6 · Cited by 5
“Conversely, iPSCs are isolated from body fluids, thus circumventing the ethical hurdle regarding cell source [257–259].”
Phytochemicals and Vitagenes for a Healthy Brain
Osakabe, N., Anfuso, C. D., Jacob, U. M., Sidenkova, A. P., Fritsch, T., Abdelhameed, A. S., Rashan, L. J., Wenzel, U., Calabrese, E. J., & Calabrese, V. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_11 · Cited by 4
Klingenstein, S., Kleger, A., Liebau, S., & Klingenstein, M. (2025) · Stem Cells and Development · doi:10.1089/scd.2025.0082 · Cited by 6
“121”
Self-citationCRISPR-Cas9-Mediated Gene Editing in Human Induced Pluripotent Stem Cells
Groen, S. L. M. I. ‘., Broeders, M., & Pijnappel, W. W. M. P. (2021) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-0716-1657-4_16 · Cited by 3
Kwon, O., Na, H.-J., Ahn, J., & Chung, K. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102950 · Cited by 3
Induced Pluripotent Stem Cells: Advances and Applications in Regenerative Medicine
Kizub, I. V., Rozhok, A. I., & Bilousova, G. (2023) · Biochemistry · doi:10.5772/intechopen.109274 · Cited by 3
Dionne, O., Sabatié, S., Fortin, F., Corbin, F., & Laurent, B. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1489190 · Cited by 4
“(Loh et al., 2009; Warren et al., 2010; Raab et al., 2014; Schlaeger et al., 2015; Kim et al., 2016).”
Induced pluripotent stem cell derivation from myoblasts
Winder, M. L., & Trokovic, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822135-8.00009-4 · Cited by 3
Sauerzopf, U., Sacco, R., Novarino, G., Niello, M., Weidenauer, A., Praschak-Rieder, N., Sitte, H. H., & Willeit, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13418 · Cited by 4
“The properties, advantages and disadvantages of various cell types are reviewed by (Raab et al., 2014).”
BackgroundModeling the Neurovascular Unit In Vitro and In Silico
Saili, K. S., Zurlinden, T. J., & Knudsen, T. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809405-1.00011-0 · Cited by 3
Cheng, S., Li, D., Zhang, R., Zhu, J., Wang, L., Liu, Q., Chen, R., & Liu, X.-M. (2020) · Current Gene Therapy · doi:10.2174/1566523220666200211105228 · Cited by 3
Tucker, H. O. (2018) · Journal of Embryology & Stem Cell Research · doi:10.23880/jes-16000110 · Cited by 2
“Reprogramming of somatic cells to ESC-like induced Pluripotent Stem Cells (iPSCs) now can be generated routinely from tissue biopsies or tumor samples [1].”
BackgroundSetthawong, P., Phakdeedindan, P., Techakumphu, M., & Tharasanit, T. (2021) · Reproduction in Domestic Animals · doi:10.1111/rda.13954 · Cited by 3
Aged human iPSC-RPE organoid cultures display hallmarks of drusen formationPreprint
Mesch, L., Pashkovskaia, N., Cora, V., Pars, S., Corti, S., Cipriano, M., Loskill, P., Körtvely, E., Kustermann, S., Mesquida, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.12.463899 · Cited by 5
Self-citationGalgani, A., Scotto, M., & Giorgi, F. S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46090607 · Cited by 3
“Fully differentiated mesenchymal cells (such as fibroblasts or circulating blood monocytes) [18,23] can be de-differentiated from iPSCs using specific protocols, and then re-programmed towards neural phenotypes [17], and even further to specific neuronal population phenotypes, such as dopaminergic…”
BackgroundThai, H. B. D., Jung, W., Choi, S., Kim, W. J., Moon, J., & Lim, B. C. (2025) · Korean Journal of Pediatrics · doi:10.3345/cep.2024.01830 · Cited by 3
“6,7) However, the intrusiveness of methods that are used to extract these cells can make it challenging to obtain cells from these sources, because they frequently reduce the pool of possible donors.”
Mashayekhi, K., Hall, V. J., Freude, K., Høffding, M. K., Labusca, L. S., & Hyttel, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-43332-5_6 · Cited by 2
Non‑viral transfection methods optimized for miRNA delivery to human dermal fibroblasts
Kucharski, M., Mrowiec, P., Białka, S., Misiołek, H., Misiołek, M., Sechman, A., Zieba, D. A., & Oclon, E. A. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.12976 · Cited by 2
Toxicity Aspects and Ethical Issues of Bioprinting
Hashimi, N. A., & Vijayavenkataraman, S. (2024) · Wiley eBooks · doi:10.1002/9781119894407.ch8 · Cited by 2
Metadata
- Authors
- Raab, S., Klingenstein, M., Liebau, S., & Linta, L.
- Affiliations
- University of Tübingen (DE)
- Corresponding author
- Liebau, Stefan
- Linta, Leonhard
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-12
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC4241335
- OpenAlex
- W2034460442
- Cited by
- 263
- References
- 83
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 28 · 2023: 21 · 2022: 20 · 2021: 35 · 2020: 27 · 2019: 26 · 2018: 19 · 2017: 21 · 2016: 22 · 2015: 7
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- German Foundation for Heart Research (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- Else Kröner-Fresenius-Stiftung (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, somatic cell reprogramming, keratinocytes, hair follicle, fibroblasts, urine-derived cells, pancreatic beta cells, synoviocytes, mesenchymal stem cells, skin biopsy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.